Connection

Armand Glassman to Female

Back to Details
This is a "connection" page, showing publications Armand Glassman has written about Female.
Armand Glassman
Connection Strength
0.193
Female
  1. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005 Apr 01; 158(1):88-91.
    View in: PubMed
    Score: 0.014
  2. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome. Ann Clin Lab Sci. 2003; 33(3):285-8.
    View in: PubMed
    Score: 0.012
  3. Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement. Ann Clin Lab Sci. 2001 Jan; 31(1):68-74.
    View in: PubMed
    Score: 0.010
  4. The relationship between age and karyotypic abnormalities in myelodysplastic syndromes. Cancer Genet Cytogenet. 1996 May; 88(1):80-2.
    View in: PubMed
    Score: 0.007
  5. Breast cancer cytogenetics: a review and proposal for clinical application. Ann Clin Lab Sci. 1996 May-Jun; 26(3):208-14.
    View in: PubMed
    Score: 0.007
  6. Implications of human T-lymphotropic virus type-I and type-II testing in donors and patients. Ann Clin Lab Sci. 1995 Sep-Oct; 25(5):373-80.
    View in: PubMed
    Score: 0.007
  7. der(1;15)(q10;10): a nonrandom chromosomal abnormality of myeloid neoplasia. Cancer Genet Cytogenet. 1995 Sep; 83(2):144-7.
    View in: PubMed
    Score: 0.007
  8. Neonatal alloimmune thrombocytopenia: current considerations. Ann Clin Lab Sci. 1994 Sep-Oct; 24(5):407-11.
    View in: PubMed
    Score: 0.007
  9. Thrombosis and coagulation abnormalities associated with cancer. Ann Clin Lab Sci. 1994 Jan-Feb; 24(1):1-5.
    View in: PubMed
    Score: 0.006
  10. The lung permeability index: a feasible measurement of pulmonary capillary permeability. Respir Med. 2011 Feb; 105(2):230-5.
    View in: PubMed
    Score: 0.005
  11. Antithymocyte serum suppression of immunity in mice immunized to Leishmania donovani. Ann Clin Lab Sci. 1990 Jul-Aug; 20(4):263-7.
    View in: PubMed
    Score: 0.005
  12. Characterization of neutrophil agglutinins in primary autoimmune neutropenia of early childhood. Ann Clin Lab Sci. 1988 Sep-Oct; 18(5):367-73.
    View in: PubMed
    Score: 0.004
  13. Resistance against Leishmania donovani induced with an aluminum hydroxide vaccine. Ann Clin Lab Sci. 1988 Jan-Feb; 18(1):72-7.
    View in: PubMed
    Score: 0.004
  14. Effect of hydroxyethyl starch (HES) in reducing parasite load in experimental visceral leishmaniasis. Ann Clin Lab Sci. 1986 Nov-Dec; 16(6):450-4.
    View in: PubMed
    Score: 0.004
  15. Leishmania donovani: immunization against infection as a function of parasite growth phase. Am J Trop Med Hyg. 1986 Nov; 35(6):1117-20.
    View in: PubMed
    Score: 0.004
  16. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005 Nov; 124(5):807-14.
    View in: PubMed
    Score: 0.004
  17. Immunity during pregnancy: lymphocyte subpopulations and mitogen responsiveness. Ann Clin Lab Sci. 1985 Sep-Oct; 15(5):357-62.
    View in: PubMed
    Score: 0.004
  18. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
    View in: PubMed
    Score: 0.003
  19. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood. 2005 Jun 15; 105(12):4573-5.
    View in: PubMed
    Score: 0.003
  20. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 2005 Mar 15; 105(6):2281-6.
    View in: PubMed
    Score: 0.003
  21. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer. 2004 Oct 25; 102(5):322-7.
    View in: PubMed
    Score: 0.003
  22. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol. 2004 Sep; 122(3):348-58.
    View in: PubMed
    Score: 0.003
  23. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol. 2004 Jun; 121(6):836-42.
    View in: PubMed
    Score: 0.003
  24. A genetically defined model for human ovarian cancer. Cancer Res. 2004 Mar 01; 64(5):1655-63.
    View in: PubMed
    Score: 0.003
  25. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
    View in: PubMed
    Score: 0.003
  26. Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol. 2003 Oct; 34(10):1022-9.
    View in: PubMed
    Score: 0.003
  27. Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction. Ann Oncol. 2002 May; 13(5):781-8.
    View in: PubMed
    Score: 0.003
  28. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum. Leuk Lymphoma. 2002 Apr; 43(4):761-5.
    View in: PubMed
    Score: 0.003
  29. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002 Feb 01; 99(3):840-9.
    View in: PubMed
    Score: 0.003
  30. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001 Oct; 116(4):543-9.
    View in: PubMed
    Score: 0.003
  31. Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia. Cancer. 2001 May 01; 91(9):1704-8.
    View in: PubMed
    Score: 0.003
  32. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001 Apr; 115(4):571-81.
    View in: PubMed
    Score: 0.003
  33. Effects of insulin on phytohemagglutinin-P, concanavalin-A, and pokeweed mitogen in diabetic and nondiabetic lymphocytes. Ann Clin Lab Sci. 1981 Jan-Feb; 11(1):9-14.
    View in: PubMed
    Score: 0.003
  34. B and T lymphocytes: quantitation, function, and clinical applicability. Ann Clin Lab Sci. 1980 Nov-Dec; 10(6):455-62.
    View in: PubMed
    Score: 0.003
  35. Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. Am J Clin Pathol. 2000 Aug; 114(2):248-57.
    View in: PubMed
    Score: 0.002
  36. Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies. Cancer. 2000 Apr 25; 90(2):126-32.
    View in: PubMed
    Score: 0.002
  37. Lymphocyte blast transformation and peripheral lymphocyte percentages in patients with sickle cell disease. Ann Clin Lab Sci. 1980 Jan-Feb; 10(1):9-12.
    View in: PubMed
    Score: 0.002
  38. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia. 1999 Jun; 13(6):869-72.
    View in: PubMed
    Score: 0.002
  39. T and B lymphocyte subpopulations in black patients with diabetes mellitus. Ann Clin Lab Sci. 1978 Nov-Dec; 8(6):467-71.
    View in: PubMed
    Score: 0.002
  40. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998 Apr; 4(4):861-7.
    View in: PubMed
    Score: 0.002
  41. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998 Mar; 16(3):1103-11.
    View in: PubMed
    Score: 0.002
  42. B and T lymphocytes: methodology and normal ranges. Ann Clin Lab Sci. 1977 Nov-Dec; 7(6):519-23.
    View in: PubMed
    Score: 0.002
  43. Downregulation of RAR alpha in mice by antisense transgene leads to a compensatory increase in RAR beta and RAR gamma and development of lymphoma. Blood. 1997 Apr 01; 89(7):2507-15.
    View in: PubMed
    Score: 0.002
  44. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997 Mar; 19(6):565-70.
    View in: PubMed
    Score: 0.002
  45. [Changes in the cell cycle in breast cancer]. Ginecol Obstet Mex. 1996 May; 64:230-5.
    View in: PubMed
    Score: 0.002
  46. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat. 1996; 37(2):179-88.
    View in: PubMed
    Score: 0.002
  47. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 1993 Jul; 4(4):285-94.
    View in: PubMed
    Score: 0.002
  48. Neutrophil agglutinins in idiopathic chronic neutropenia of early childhood. Am J Dis Child. 1986 Jan; 140(1):65-8.
    View in: PubMed
    Score: 0.001
  49. Adoptive transfer of vaccine-induced resistance to Leishmania donovani. Am J Trop Med Hyg. 1985 Nov; 34(6):1095-7.
    View in: PubMed
    Score: 0.001
  50. A computerized system for the identification of alloimmune neutropenia in neonates. Comput Methods Programs Biomed. 1985 Aug; 20(3):241-7.
    View in: PubMed
    Score: 0.001
  51. Autoimmune neutropenia in early infancy: a review. Ann Clin Lab Sci. 1982 Sep-Oct; 12(5):356-67.
    View in: PubMed
    Score: 0.001
  52. Role of neutrophil antigen NA1 in an infant with autoimmune neutropenia. Am J Dis Child. 1982 Aug; 136(8):718-21.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.